Pfizer, GlaxoSmithKline and Teva lead price hikes on more than 400 drugs in 2022

The 2022 new calendar is less than a week away, and major pharmaceutical companies have quickly implemented price increases on more than 400 drugs

Pfizer's price hike was the largest of any company, raising the price tags of nearly 100 drugs, ranging from a 0.

GlaxoSmithKline and Teva each raised prices on more than 30 products

French drugmaker Sanofi raised list prices on 13 drugs, ranging from a 2.

Meanwhile, Gilead also raised prices on 11 drugs by 5.

Of the more than 400 drugs that saw price increases, the biggest increase was Pfizer's Solu-Cortef, which increased its price by a staggering 16.

Piper Sandler analysts said in a recent report that while price increases for biopharmaceuticals "appear to be more aggressive" in the New Year's week than in past years, it could also mean "a relatively modest increase in mid-to-late 2022.

Judging from the preliminary analysis of data in 2022, so far, the average data on drug price increases in January 2022 is still lower than the 589 drug price increases reported by GoodRx in early 2021, with an average increase of 4.

Original English text: https:// href="https://" target="_blank" _href="https://">https://